- ACUTE PROMYELOCYTIC LEUKEMIA (APL ) [A 24]
- ALFA FETO PROTEIN (AFP) [A 86]
- ALK-1 [A 87]
- ALPHA-FETOPROTEIN (AFP)[PHOTO] [A 182]
- ALPHA-FETOPROTEIN ( LIVER CANCER MONITOR) [A 183]
- AMA (ANTI MITOCHONDRIAL ANTIBODIES WITH TITRE (Reflex to end titre to all positive cases ) [A 187]
- ANDROSTENEDIONE (A4) [A 202]
- BCR-ABL(9:22) QUALITATIVE [B 02]
- BCR-ABL(9:22) QUANTITATIVE [B 03]
- B-CELL GENE REARRANGEMENT [B 08]
- BETA-2-MICROGLOBULIN [B 12-13]
- BETA HUMAN CHORIONIC GONODOTROPIN
- HORMONE [B 14]
- BETA HUMAN CHORIONIC GONODOTROPIN
- HORMONE [B 15-18]
- BIOPSY (BONE HISTOPATHOLOGY) [B 24-25]
- BIOPSY (LARGE TISSUE / SPECIMEN ) [B 26]
- BIOPSY (MEDIUM TISSUE / SPECIMEN ) [B 27]
- BIOPSY (PHOTO - MORE THAN ONE ) [B 28]
- BIOPSY (PHOTO – SINGLE) [B 29]
- BIOPSY (SKIN HISTOPATHOLOGY - PHOTO ) [B 30]
- BIOPSY (SKIN HISTOPATHOLOGY) [B 31]
- BIOPSY (SMALL TISSUE BIOPSY / SPECIMEN) [PHOTO] [B 32]
- BIOPSY H & E SLIDE FOR REVIEW (MORE THAN 2 SLIDES / PARAFFIN BLOCKS [PHOTO] [B 33]
- BIOPSY H & E SLIDE FOR REVIEW (MORE THAN 2 SLIDES / PARAFFIN BLOCKS [B 34]
- BIOPSY H & E SLIDE FOR REVIEW (UPTO 2 SLIDES / PARAFFIN BLOCKS) [B 35]
- BIOPSY; SLIDE FOR REVIEW (UPTO 2 SLIDES / PARAFFIN BLOCKS )[PHOTO] [B 36]
- BIOPSY-BRAIN BIOPSY WITH SPECIAL STAINS (PTAH & RETICULIN) [B 37]
- BIOPSY-MUSCLE BIOPSY WITH SPECIAL STAINS (MASSON TRICHOME ) [B 38]
- BIOPSY-NERVE BIOPSY WITH SPECIAL STAINS (LUXOL FAST & GBS [B 39]
- BIOPSY-RENAL BIOPSY WITH SPECIAL STAINS (PAS, GMS & OTHER AS REQUIRED FOR EX:
- CONGORED IN AMYLOIDOSIS) [B 40]
- BRCA 1 & 2 GENETIC TEST - BREAST CANCER [B 57]
- CA 125 [C 10-11]
- CA 15-3 [C 12]
- CA 19-9 [C 13-14]
- CA 72.4 [C 15]
- CALCITONIN[PHOTO] [C 20]
- CARCINOEMBRYONIC ANTIGEN (CEA) [C 39-40]
- CATECHOLAMINES [C 44]
- CATECHOLAMINES [C 45]
- CHROMOSOME ANALYSIS IN HEMATOLOGICAL DISORDERS [c 78]
- CYTOGENETICS: AML 1/ ETO t(8:21) [c 145]
- CYTOGENETICS: HER2/neu [c 152]
- CYTOGENETICS: Inv(16) [c 153]
- CYTOGENETICS: MLL 11q rearrangement [C 155]
- DEHYDROEPIANDROSTERONE (DHEA)
- E-CADHERIN [PHOTO] [E 04]
- EGFR Gene AMPLIFICATION [E 08]
- EML-4 ALK Translocation by FISH [E 10]
- FINE NEEDLE ASPIRATION CYTOLOGY (FNAC, NON- GYNAEC CYTOLOGY) (F 18]
- FINE NEEDLE ASPIRATION CYTOLOGY (FNAC, NON- GYNAEC CYTOLOGY (PHOTO [F 19]
- GASTROENTERITIS SCREENING PANEL [G 07]
- HEPAR-1 [PHOTO](Anti- Human Hepatocyte) [H 29]
- HER2/neu [H 52]
- HPV DNA DETECTOR [H 90-94]
- HYBRID CAPTURE 2 HIGH RISK HPV DNA TEST [H 101]
- IgVH GENE MUTATION [I 13]
- MALIGNANT TUMORS: LYMPHOMA v/s CARCINOMA (CD45),CK[PHOTO] [M 05]
- MELANOMA (S- 100/HMB- 45/Melan-A )[PHOTO] [M 16]
- MLL 11q rearrangement [M 27]
- PIVKA-II (DecarboxyProthrombin ) [P 21]
- PLACENTAL ALKALINE PHOSPHATASE[PHOTO] [P 22]
- SEROTONIN [S 08-09]
- THINPREP CYTOLOGY [T 25-26]
- THYROID TRANSCRIPTION FACTOR (TTF-1 )[PHOTO] [T 34-35]
- VANILLYLMANDELIC ACID (VMA) [V03]
- WILM'S TUMOR PROTEIN 1 (WT1[PHOTO] [W 07-08]
- ZAP-70 [Z 01]
- 14 Q32 / IGH GENE REARRANGEMENT [QC 1151]
- 17-KETOSTEROIDS [QC1154]
- ACUTE LEUKEMIA PANEL FLOWCYTOMETRY CD10,CD19,CD20,CD22,CD3,C D5,CD7,CD13,CD33,CD34,CD117,HLA DR, CYTOPLASMIC MARKERS WILL BE DONE IF REQUIRED FOR DIAGNOSIS MPO, CD3, CD 79A [QPA7]
- ACUTE MYELOID LEUKEMIA (AML PANEL) CD7, CD19, CD13, CD14, CD15, CD33, CD34, CD117, CD41, CD61, GLYCOPHORIN A, HLA-DR [QPA8]
- ADENOCARCINOMA V/S MALIGNANT MESOTHELIOMA PANEL CEA, EMA, VIMENTIN, LWCK)[PHOTO] [QPA9]
- BREAST CANCER MONITOR I CA 15-3, CEA,VITAMIN D [QPB4]
- BREAST CANCER PROGNOSIS TUMOR PANEL ER, PGR, DNA PLOIDY, PS2 [PHOTO] [QPB5]
- BREAST CANCER PROGNOSIS TUMOR PANEL ER, PGR, DNA PLOIDY [PHOTO] [QPB6]
- BREAST CANCER PROGNOSIS TUMOR PANEL ER, PGR, DNA PLOIDY, CATHESPIN D [PHOTO] [QPB7]
- BREAST CANCER PROGNOSIS TUMOR PANEL ER, PGR, DNA PLOIDY, CATHESPIN D, EGFR, HER 2neu, KI -67, PS2, P53 [PHOTO] [QPB8]
- BREAST CANCER PROGNOSIS TUMOR PANEL ER, PGR, HER 2-neu, CATHESPIN D, EGFR, DNA PLOIDY [PHOTO] [QPB9]
- CUSTOM LEUKEMIA PANEL (SIX SURFACE MARKERS) [QPC12]
- CUSTOM LEUKEMIA PANEL (FOUR SURFACE MARKERS ) [QPC13]
- CYTOCHEMISTRY PANEL FOR LEUKEMIAS (PERIODIC ACID SCHIFF,SUDAN BLACK B and MYELOPEROXIDASE) [QPC15]
- FLOWCYTOMETRY PANEL CD3,CD16,CD56,CD45 [CPF18]
- LEUKEMIA TRANSLOCATION PANEL A (t(1;19 (q23;p13, Inv(16(p13;q22, t(9;22 (q34;q11, t(4;11 (q21;q23, t(12;21 (p13;q22, t(15;17(q22;q22, t(8;21(q22;q22 ) [CPL1]
- LEUKEMIA TRANSLOCATION PANEL B (Inv(16(p13;q22, t(15;17(q22;q22, t(8;21(q22;q22) [QPL2]
- LEUKEMIA TRANSLOCATION PANEL C (t(1;11 (p32;q23, t(1;11 (p21;q23, t(4;11 (q21;q23, t(6;11 (q27;q23, t(9;11 (p22;q23, t(10;11 (p12;q23, t(11;17 (q23;q21, t(11;19 (q23;p13.1, t(11;19 (q23;p13.3, Dup MLL (11q23, t(X;11 (q13;q23 ) [CPL3]
- LEUKEMIA TRANSLOCATION PANEL D t(1; 19 (q23; p13, t(9; 22 (q34; q11, t(4;11 (q21; q23, t(1;11 (p32; q23, t(11; 19 (q23; p13.3, t(X;11 (q13; q23) [CPL4]
- LEUKEMIA TRANSLOCATION PANEL E t(9; 22 (q34; q11, Dup MLL (11q23, t(11; 17 (q23; q21), [CPL5]
- LEUKEMIA TRANSLOCATION PANEL F t(1; 19 (q23; p13, t(9; 22 (q34; q11, t(4;11 (q21; q23 and t(12; 21 (p13; q22,) [CPL6]
- LIVER CANCER PROFILE AFP, CEA, Ferritin, LFT [CPL10]
- LYMPHOMA [PHOTO] DIFFERENTIAL DIAGNOSIS PANEL CD30, CD15, CD20, CD3, CD45 [QPL19]
- METATASTIC TUMOUR BREAST ER, PgR, Her-2/neu, GCDFP-15[PHOTO] [QPM10]
- MULTIPLE MYELOMA PROFILE Beta 2 Microglobulin, Ferritin,IgA,IgG,IgM, Immunofixation electrophoresis [QPM11]
- MYELOMA PANEL CD38,CD56,CD19.KAPPA,LA MBDA,CD45 [QPM13]
- NATURAL KILLER CELL EVALUATION %CD16+56,ABS CD16+CD56 [QPN1]
- NATURAL KILLER PANEL CD3,CD16,CD56,CD45 [QPN2]
- PANCREATIC CANCER MONITOR PANEL (CA 19-9,) CEA,PSA [QPP2]
- TESTICULAR CANCER MONITOR AFP & HCG [QPT1]
- Testicular cancer profile AFP, Beta-HCG (Total), CEA, E2,Prolactin,Ferritin.[QPT12]
